|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:approves
|
gptkb:2013
|
|
gptkbp:brand
|
gptkb:Quillivant_XR
|
|
gptkbp:category
|
gptkb:C
|
|
gptkbp:clinical_trial
|
NCT01720012
NCT01720025
NCT01720038
|
|
gptkbp:color
|
gptkb:orange
|
|
gptkbp:contraindication
|
gptkb:Ophthalmology
heart problems
history of drug abuse
|
|
gptkbp:dosage_form
|
gptkb:liquid
|
|
gptkbp:duration
|
up to 12 hours
|
|
gptkbp:effective_date
|
FDA approved
|
|
gptkbp:form
|
oral suspension
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Quillivant XR
|
|
gptkbp:ingredients
|
gptkb:Sannin
|
|
gptkbp:label
|
gptkb:Neos_Therapeutics,_Inc.
|
|
gptkbp:manufacturer
|
gptkb:Neos_Therapeutics
|
|
gptkbp:mechanism_of_action
|
CNS stimulant
|
|
gptkbp:ndc
|
68084-001
|
|
gptkbp:packaging
|
gptkb:bottle
|
|
gptkbp:patient_population
|
children and adolescents
|
|
gptkbp:performance
|
gptkb:II
|
|
gptkbp:related_products
|
gptkb:Daytrana
gptkb:Concerta
gptkb:Ritalin
gptkb:Adderall
Metadate
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:safety
|
monitor for cardiovascular events
monitor for psychiatric symptoms
not for use in patients with hyperthyroidism
not for use in patients with severe anxiety
not for use in patients with a history of tics.
risk of abuse and dependence
|
|
gptkbp:side_effect
|
anxiety
nausea
decreased appetite
insomnia
dry mouth
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:strength
|
100 mg/5 m L
|
|
gptkbp:taste
|
gptkb:fruit
|
|
gptkbp:type_of_care
|
once daily dosing
|
|
gptkbp:used_for
|
treatment of ADHD
|
|
gptkbp:bfsParent
|
gptkb:Sannin
|
|
gptkbp:bfsLayer
|
5
|